Literature DB >> 30909316

Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension.

Leonello Fuso1,2, Dario Pitocco3,2, Raffaele Antonelli-Incalzi4.   

Abstract

In patients with type 1 and type 2 diabetes mellitus (DM), respiratory function abnormalities have been reported with regard to lung volumes, pulmonary diffusing capacity, control of ventilation, bronchomotor tone, and neuroadrenergic bronchial innervation. Indeed, the decrease in lung volumes and the impairment of diffusing capacity might have important clinical implications. Furthermore, there is an increasing evidence of a link between DM and pulmonary hypertension (PH) related to an involvement of the pulmonary vascular structures. These findings support the view of the lung as target organ in DM. In this paper, we briefly describe the main derangements of the respiratory system in DM and the inherent mechanisms.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetic microangiopathy; pulmonary hypertension; respiratory function

Mesh:

Year:  2019        PMID: 30909316     DOI: 10.1002/dmrr.3159

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

1.  Development and Validation of a Model That Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.

Authors:  Jing Yang; Sheng Jiang
Journal:  Int J Gen Med       Date:  2022-05-20

2.  Clinico-Epidemiological Profiles of COVID-19 Elderly Patients in Guwahati City, Assam, India: A Cross-Sectional Study.

Authors:  Priyanka Rana Patgiri; Vinoth Rajendran; Abdul B Ahmed
Journal:  Cureus       Date:  2022-04-11

3.  Nomogram Model for Screening the Risk of Type II Diabetes in Western Xinjiang, China.

Authors:  Yushan Wang; Yushan Zhang; Kai Wang; Yinxia Su; Jinhui Zhuge; Wenli Li; Shuxia Wang; Hua Yao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-07       Impact factor: 3.168

4.  Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.

Authors:  Lihua Zhu; Zhi-Gang She; Xu Cheng; Juan-Juan Qin; Xiao-Jing Zhang; Jingjing Cai; Fang Lei; Haitao Wang; Jing Xie; Wenxin Wang; Haomiao Li; Peng Zhang; Xiaohui Song; Xi Chen; Mei Xiang; Chaozheng Zhang; Liangjie Bai; Da Xiang; Ming-Ming Chen; Yanqiong Liu; Youqin Yan; Mingyu Liu; Weiming Mao; Jinjing Zou; Liming Liu; Guohua Chen; Pengcheng Luo; Bing Xiao; Changjiang Zhang; Zixiong Zhang; Zhigang Lu; Junhai Wang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Gang Peng; Ping Ye; Jun Yang; Yufeng Yuan; Xiaodong Huang; Jiao Guo; Bing-Hong Zhang; Hongliang Li
Journal:  Cell Metab       Date:  2020-05-01       Impact factor: 27.287

5.  Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.

Authors:  Shengwei Wang; Hao Cui; Keshan Ji; Changpeng Song; Changwei Ren; Hongchang Guo; Changsheng Zhu; Shuiyun Wang; Yongqiang Lai
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951

6.  Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm.

Authors:  Xiaoting Lu; Zhenhai Cui; Feng Pan; Lingli Li; Lin Li; Bo Liang; Lian Yang; Chuansheng Zheng
Journal:  Acta Diabetol       Date:  2021-01-08       Impact factor: 4.280

7.  The diabetic lung: An easy target for SARS-CoV-2?

Authors:  Irene Caruso; Francesco Giorgino
Journal:  Diabetes Metab Res Rev       Date:  2020-06-18       Impact factor: 8.128

Review 8.  Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis.

Authors:  Giovanni Corona; Alessandro Pizzocaro; Walter Vena; Giulia Rastrelli; Federico Semeraro; Andrea M Isidori; Rosario Pivonello; Andrea Salonia; Alessandra Sforza; Mario Maggi
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.